Metraipolis › archive › dc_8ccc7ea3e5bd

Advances in Immune Checkpoint Inhibitors for Cancer Treatment — Europe PMC PMID:42279386

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42279386
DOI
10.3390/cancers18111804
License (as archived)
solo-consultazione
Archived
2026-11-01T00:26:14.986Z
SHA-256 of the archived text
54df3666c472a1aa6c90284e07d4a03d79d3f7b4e8f1367a8aa27666b4167959
Stable URL of this page
https://metraipolis.com/documento/dc_8ccc7ea3e5bd

How to cite

Advances in Immune Checkpoint Inhibitors for Cancer Treatment — Europe PMC PMID:42279386 — Europe PMC (en), https://europepmc.org/article/MED/42279386 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8ccc7ea3e5bd (Metraipolis archive dc_8ccc7ea3e5bd, sha256 54df3666c472a1aa6c90284e07d4a03d79d3f7b4e8f1367a8aa27666b4167959)
BibTeX
@misc{dc8ccc7ea3e5bd,
  title = {Advances in Immune Checkpoint Inhibitors for Cancer Treatment — Europe PMC PMID:42279386},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42279386},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8ccc7ea3e5bd; sha256 54df3666c472a1aa6c90284e07d4a03d79d3f7b4e8f1367a8aa27666b4167959},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279386. Agents can read the archived copy with the MCP tool read_document.